A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder

The core symptoms of autism spectrum disorder (ASD) include impaired social communication, repetitive behaviors, and restricted interests. No effective pharmacotherapy for these core deficits exists. Within the domain of social communication, the vasopressin system is implicated in social cognition...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuropsychopharmacology
Main Authors: Umbricht, Daniel, del Valle Rubido, Marta, Hollander, Eric, McCracken, James T, Shic, Frederick, Scahill, Lawrence, Noeldeke, Jana, Boak, Lauren, Khwaja, Omar, Squassante, Lisa, Grundschober, Christophe, Kletzl, Heidemarie, Fontoura, Paulo
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5520775/
https://ncbi.nlm.nih.gov/pubmed/27711048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2016.232
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados